The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
about
Inflammation and insulin resistanceAnalysis of domains in the IKKalpha and IKKbeta proteins that regulate their kinase activityPreadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyReye syndrome--insights on causation and prognosisChromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitroRegulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.Binding of manumycin A inhibits IkappaB kinase beta activityLarge-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathwaysInflammation, stress, and diabetesIkappaB kinase alpha (IKKalpha) regulation of IKKbeta kinase activitySalsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studiesAnemia in frailtyThe SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitroBeyond reverse pharmacology: Mechanism-based screening of Ayurvedic drugsPathogen recognition and inflammatory signaling in innate immune defensesThe protein kinase IKKepsilon regulates energy balance in obese miceTherapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancerCyclooxygenase-2 is a neuronal target gene of NF-kappaBNF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamideMultiple Targets of Salicylic Acid and Its Derivatives in Plants and AnimalsRoles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic ApproachesMarine Diterpenoids as Potential Anti-Inflammatory AgentsNew insights into insulin: The anti-inflammatory effect and its clinical relevanceIncreasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular AscorbateThe therapeutic value of targeting inflammation in gastrointestinal cancersMolecular targets of aspirin and cancer prevention.Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitusIRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L proteinAspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expressionAspirin prevents apoptosis and NF-kappaB activation induced by H2O2 in hela cellsCyclooxygenase in the treatment of glioma: its complex role in signal transductionNonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferationSalicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigenAnother reason for taking aspirinEffect of acetylsalicylic acid on endogenous I kappa B kinase activity in lung epithelial cellsEvidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidantsSelective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsNucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosisCOX-2 inhibitors vs. NSAIDs in gastrointestinal damage and preventionRelease of tumor necrosis factor-alpha and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin
P2860
Q22241893-49D8E93D-5E9A-4CC5-AFF3-9E57EC85D284Q22253426-6781D9C0-9D1D-4CB2-9473-523365910F9FQ22299231-D9DBF7C5-EDAF-4CDD-987D-8FBD312AD842Q22299327-9BFF6EB2-553F-4A1F-8144-9DB8D424FE94Q24292056-5B5AE8B9-3C47-4CBF-9CE3-DC0194EC06ACQ24295084-04115B7B-2772-4327-96DB-059C1F0E827EQ24297512-2C4B5801-ACCA-456E-81A9-903CCB4319EAQ24302300-D90F896E-52BC-4851-9601-D6456242AC76Q24523336-B5450C14-EEB9-4C19-A691-AE8030667EC5Q24554217-A30FD6DD-7A7C-4953-8E0D-CFB4BD66A097Q24562012-8E4C0FA4-2F5F-4291-8BDF-E58A0AF4BEDAQ24569641-82D2068B-A08E-4BD9-B187-4759A7ED4D2FQ24608829-3A00AF02-86D8-42EF-8B82-EEF8E4FC51F5Q24611403-C65A86EB-01CC-434E-9A83-3405D5CE40C4Q24643034-ABFA4862-C453-4777-94EA-8666D5393852Q24658201-060EB994-3F9E-4BE0-8B3D-C0A5D70333DAQ24681630-7360D9CA-E778-48E8-A835-5B482C4280A0Q24795366-3940E834-7409-4963-9B58-593D46EF767AQ24804016-60FA72BC-ADB3-468B-950F-4AF4D72D9C6AQ26745979-43B14A00-5823-41DB-A8E2-2385F9D416C0Q26752576-A147B0FA-8EBA-4CBB-87C7-372DC8C5E5D2Q26779952-16879EAE-E8B0-481D-BB7B-0A73AD9452A1Q26822374-FE2E4505-FBEF-48DF-908F-DE3C8938E6ECQ27021794-0A193202-C647-4A14-90D3-6EDCFC3F4A28Q27024203-12E0A659-6391-4E17-B94C-3D874AE3B003Q27687847-A382AB1A-94AC-4A61-8B37-F4C4487ECB17Q28081094-3BC4A54E-2249-4FF8-BA3B-A626D448A076Q28140837-01A59415-3708-44F4-87A6-90A32BAD8AE6Q28165533-9A79600C-1FD5-48F1-ACCA-E95EF5B93C97Q28167024-A137FB67-6DAF-49CC-8462-D6BF316B7DF3Q28168685-5B059235-8F55-4949-8832-4CBB4131CFB0Q28171193-9C0A0E2B-571D-4FA0-A365-C4305DEF6703Q28174689-A972F9C1-A75D-4211-8AE5-92D91FCA70F2Q28174789-EC2A9034-DBA3-42C4-9C2C-5A820E5C72E0Q28174796-79CD6B93-510E-48B6-9D3C-31D077D3D69DQ28180502-9E4981B9-C756-4517-85A7-361D77951298Q28181159-0D990655-22CD-401C-BCF0-895ADE723292Q28182225-B39DABE1-D0F1-453B-92B3-36F7AEE1CCE4Q28182917-1DBA62E9-2D22-4C48-B979-D2464AB73403Q28185054-E83403DD-01B1-41FA-A0EF-0AEA1BEE0854
P2860
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@ast
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@en
type
label
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@ast
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@en
prefLabel
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@ast
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@en
P2093
P3181
P356
P1433
P1476
The anti-inflammatory agents a ...... ivity of I(kappa)B kinase-beta
@en
P2093
P2888
P3181
P356
10.1038/23948
P407
P577
1998-11-05T00:00:00Z
P6179
1049122030